Management Fee Arrangements

RNS Number : 0955C
Polar Capital Global Health Tst PLC
14 October 2020
 

POLAR CAPITAL GLOBAL HEALTHCARE TRUST PLC (the 'Company')

 

LEI: 549300YV7J2TWLE7PV84

 

14 October 2020

 

 

 

 

Management Fee Arrangements

 

 

The Board of Directors announces that following discussion with Polar Capital they have agreed a reduction in the management fee charged for managing the portfolio.

 

The base management fee prior to the revision was 0.85% per annum based on the lower of the market capitalisation and adjusted net asset value.

 

The revised management fee, which is in place with effect from 1 October 2020, is 0.75% per annum based on the lower of the market capitalisation and adjusted net asset value.

 

All other terms within the Investment Management Agreement remain unchanged.

 

The Chairman commented: 'The absolute performance of the Trust has been positive in recent months, but its relative performance has been behind its benchmark. The Board appreciates that Polar Capital has had regard to this and has proposed this material reduction in the management fee rate. The Board remains confident in the Investment Manager's strategic approach to investing in the healthcare market and will report in more detail in the forthcoming Annual Report for the year ended 30 September 2020'.

 

 

For further information please contact:

Lisa Arnold - Chairman

Polar Capital Global Healthcare Trust Plc

 

Iain Evans

Polar Capital Head of Global Distribution

 

Tracey Lago

Company Secretary

Tele: 020 7227 2700

 

 

Tele. 020 7227 2740

 

 

Tele. 020 7227 2742

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCDZMMGZDFGGZM
UK 100

Latest directors dealings